Lyell Immunopharma (LYEL) VP Veronica Sanchez Bulis Sells 217 Shares

What Happened Veronica Sanchez Bulis, VP and Corporate Controller of Lyell Immunopharma (LYEL), disposed of 217 shares on 2026-05-11. The reported proceeds totaled $4,103; the weighted average sale price was $18.91 per share (sale prices ranged $18.91–$19.30). Footnotes indicate the shares were automatically sold to cover tax withholding from the settlement of vested restricted stock units (i.e., a sell-to-cover).

Key Details

• Transaction date: 2026-05-11; Form 4 filed: 2026-06-15 (filed late; Form 4s are typically due within 2 business days)
• Reported sale type: Open market/private sale (code S); labeled as automatic tax withholding (sell-to-cover)
• Shares sold: 217; weighted avg price: $18.91; price range: $18.91–$19.30
• Proceeds: $4,103 (reported)
• Shares owned after the transaction: Not specified on this Form 4
• Footnote: Issuer or reporting person will provide breakdown of number of shares sold at each price within the reported range upon SEC/issuer/stockholder request

Context This was a routine sell-to-cover tied to RSU vesting (tax withholding), not a discretionary sale signaling a change in investment view. Such automated transactions are common for employees receiving equity compensation. The late filing is an administrative detail and may attract SEC staff or disclosure inquiries but does not by itself indicate substantive trading concerns.